Antistaphylococcal Efficacy of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Polymicrobial Infection with MSSA Bacteremia or Pneumonia

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Sources (<i>N</i> = 92)</td><td class="align_center"><i>n</i> (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Lung</td><td class="align_center">45 (48.9)</td></tr><tr><td class="align_left">Blood</td><td class="align_center">18 (19.6)</td></tr><tr><td class="align_left">Urine</td><td class="align_center">14 (15.2)</td></tr><tr><td class="align_left">SSTI</td><td class="align_center">9 (9.8)</td></tr><tr><td class="align_left">Abdomen</td><td class="align_center">6 (6.5)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>SSTI: skin and soft tissue infection.<br/></div></td></tr></table>

Advances in Pharmacological and Pharmaceutical Sciences

tab2

Table 2

Table 2: Antistaphylococcal Efficacy of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Polymicrobial Infection with MSSA Bacteremia or Pneumonia 

Table 2 | Antistaphylococcal Efficacy of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Polymicrobial Infection with MSSA Bacteremia or Pneumonia 